Trial Outcomes & Findings for Heidelberg Edge Perimetry (HEP) Detecting Glaucomatous Visual Field Defects (NCT NCT02526654)

NCT ID: NCT02526654

Last Updated: 2019-09-16

Results Overview

Pearson's correlation coefficient between Heidelberg Edge Perimeter (HEP) and Octopus Visual Field (OVF) Mean Deviation (MD) for glaucoma patients and controls to determine if HEP can detect glaucoma as well as OVF. The closer the values of both parameters for both machines, the better comparable the two machines are to each other in detecting glaucoma.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

115 participants

Primary outcome timeframe

Baseline visit, 1 hour

Results posted on

2019-09-16

Participant Flow

Patients were recruited from the Glaucoma Service at Wills Eye Hospital between December 2014 and June 2015. Healthy controls were recruited from staff, family and friends.

Before study tasks, Informed Consent was conducted and obtained according to the International Conference on Harmonization Good Clinical Practices (ICH GCP) guidelines with opportunity for all questions to be answered.

Participant milestones

Participant milestones
Measure
Glaucoma Subjects
Subjects with glaucoma were recruited based on characteristic glaucomatous disc damage and visual field changes.
Healthy Controls
Healthy subjects that do not have glaucoma and have no other eye diseases.
Overall Study
STARTED
79
36
Overall Study
COMPLETED
79
36
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Heidelberg Edge Perimetry (HEP) Detecting Glaucomatous Visual Field Defects

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Glaucoma Subjects
n=79 Participants
Subjects with glaucoma were recruited based on characteristic glaucomatous disc damage and visual field changes from the Glaucoma Service at Wills Eye Hospital in Philadelphia, Pennsylvania. They will perform visual field with Heidelberg Edge Perimeter and Octopus visual field. Optical Coherence Tomography will image the retinal nerve fiber layer.
Healthy Controls
n=36 Participants
Healthy control subjects that do not have glaucoma and are recruited for testing will perform visual field with Heidelberg Edge Perimeter and Octopus visual field from staff, family and friends of the Glaucoma Service at Wills Eye Hospital in Philadelphia, Pennsylvania. Optical Coherence Tomography will image the retinal nerve fiber layer.
Total
n=115 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
23 Participants
n=99 Participants
24 Participants
n=107 Participants
47 Participants
n=206 Participants
Age, Categorical
>=65 years
56 Participants
n=99 Participants
12 Participants
n=107 Participants
68 Participants
n=206 Participants
Sex: Female, Male
Female
46 Participants
n=99 Participants
23 Participants
n=107 Participants
69 Participants
n=206 Participants
Sex: Female, Male
Male
33 Participants
n=99 Participants
13 Participants
n=107 Participants
46 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
21 Participants
n=99 Participants
15 Participants
n=107 Participants
36 Participants
n=206 Participants
Race (NIH/OMB)
White
55 Participants
n=99 Participants
17 Participants
n=107 Participants
72 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=99 Participants
4 Participants
n=107 Participants
7 Participants
n=206 Participants
Region of Enrollment
United States
79 participants
n=99 Participants
36 participants
n=107 Participants
115 participants
n=206 Participants

PRIMARY outcome

Timeframe: Baseline visit, 1 hour

Pearson's correlation coefficient between Heidelberg Edge Perimeter (HEP) and Octopus Visual Field (OVF) Mean Deviation (MD) for glaucoma patients and controls to determine if HEP can detect glaucoma as well as OVF. The closer the values of both parameters for both machines, the better comparable the two machines are to each other in detecting glaucoma.

Outcome measures

Outcome measures
Measure
Glaucoma Subjects
n=79 Participants
79 glaucoma subjects defined by characteristic glaucomatous disc damage and visual field changes
Healthy Controls
n=36 Participants
36 healthy control subjects with no glaucoma or other eye diseases.
Correlation Coefficient Between HEP and OVF Mean Deviation (MD)
-.86 Pearson's correlation coefficient
-.37 Pearson's correlation coefficient

SECONDARY outcome

Timeframe: Month 6 visit, 1 hour

Population: not all eyes were included in this sub- analysis. inconclusive results were not included.

A subgroup of participants were randomly selected to return at 3 and 6 months for repeat testing. Not all eyes were included. Repeatability of optical coherence tomography (OCT) to consistently detect minimum rim width (MRW) global thickness will be assessed by Pearson's interclass correlation coefficients (ICC). A larger ICC indicates measurements have greater repeatability. Greater than 0.75 indicated excellent repeatability; 0.40 to 0.75 indicated fair to good, and less than 0.40 indicated poor reliability.

Outcome measures

Outcome measures
Measure
Glaucoma Subjects
n=36 eyes
79 glaucoma subjects defined by characteristic glaucomatous disc damage and visual field changes
Healthy Controls
n=59 eyes
36 healthy control subjects with no glaucoma or other eye diseases.
Repeatability of Optical Coherence Tomography (OCT) Parameters
.99 Intraclass correlation coefficients
Interval 0.99 to 1.0
.99 Intraclass correlation coefficients
Interval 0.99 to 1.0

SECONDARY outcome

Timeframe: Baseline visit, 1 hour

Population: Not all eyes (automated reports) met inclusion criteria. Healthy control eye were was not included in this portion of the study. Only glaucoma subgroup received clinical interpretations by 3 glaucoma specialists.

Heidelberg Edge Perimeter (HEP) Visual Field (VF) and spectral domain optical coherence tomography (SD OCT) printouts from only the glaucoma subgroup were assessed. Retinal Nerve Fiber Layer (RNFL) and Minimum Rim Width (MRW) from SD OCT and HEP VF automated reports were compared to the clinical interpretations by 3 glaucoma specialists.

Outcome measures

Outcome measures
Measure
Glaucoma Subjects
n=53 eyes
79 glaucoma subjects defined by characteristic glaucomatous disc damage and visual field changes
Healthy Controls
36 healthy control subjects with no glaucoma or other eye diseases.
Correlations Between Structure-function Automated Report and Clinical Impression
0.62 Kappa
Interval 0.54 to 0.7

Adverse Events

Glaucoma Subjects

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Healthy Controls

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. L. Jay Katz

Wills Eye Hospital, Glaucoma Research Center

Phone: 215-928-3123

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place